BAX (Baxter International) 3-Month Share Buyback Ratio: -0.42% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BAX Baxter International Inc BAX
60 GF Score
Price $23.30
GF Value $34.41
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Baxter International 3-Month Share Buyback Ratio?

Baxter International BAX +4.00% 60 3-Month Share Buyback Ratio is -0.42 as of Mar. 2026. GuruFocus rates BAX with a GF Score™ of 60/100 and a GF Value™ of $34.41 (Possible Value Trap). The stock has 8 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Baxter International's current 3-Month Share Buyback Ratio was -0.42%.


Baxter International  (NYSE:BAX) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Baxter International 3-Month Share Buyback Ratio Related Terms


BAX vs ALGN, SOLV, COO: 3-Month Share Buyback Ratio Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International 3-Month Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Baxter International's 3-Month Share Buyback Ratio falls into.


BAX
60GF Score
Baxter International Inc BAX
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International 3-Month Share Buyback Ratio Calculation

Baxter International's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Dec. 2025 )
=(514.281 - 516.447) / 514.281
=-0.42%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of -0.42 mean?
Baxter International (BAX) has a 3-Month Share Buyback Ratio of -0.42 as of Mar. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Baxter International and its competitors.
Is Baxter International's 3-Month Share Buyback Ratio too high?
Baxter International's current 3-Month Share Buyback Ratio is -0.42. Overall, Baxter International has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's 3-Month Share Buyback Ratio compare to ALGN and SOLV?
Baxter International's 3-Month Share Buyback Ratio of -0.42 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Baxter International and its competitors. Baxter International's current 3-Month Share Buyback Ratio is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Possible Value Trap. The stock's GF Value™ is $34.41, compared to a current price of $23.30 — trading 32.3% below its estimated fair value. The current 3-Month Share Buyback Ratio is -0.42. Baxter International's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Baxter International (BAX), the current 3-Month Share Buyback Ratio is -0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of $23.30 is trading 32.3% below its estimated GF Value™ of $34.41. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for BAX:

  • 3-Month Share Buyback Ratio: -0.42
  • GF Value™: $34.41 vs. price of $23.30 (32.3% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
60GF Score

Get the complete analysis for BAX

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.30
Price
$34.41
GF Value